| Product NDC: | 42806-018 | 
| Proprietary Name: | Sulindac | 
| Non Proprietary Name: | Sulindac | 
| Active Ingredient(s): | 150 mg/1 & nbsp; Sulindac | 
| Administration Route(s): | ORAL | 
| Dosage Form(s): | TABLET | 
| Coding System: | National Drug Codes(NDC) | 
| Product NDC: | 42806-018 | 
| Labeler Name: | Epic Pharma, LLC | 
| Product Type: | HUMAN PRESCRIPTION DRUG | 
| FDA Application Number: | ANDA072710 | 
| Marketing Category: | ANDA | 
| Start Marketing Date: | 20100125 | 
| Package NDC: | 42806-018-01 | 
| Package Description: | 100 TABLET in 1 BOTTLE (42806-018-01) | 
| NDC Code | 42806-018-01 | 
| Proprietary Name | Sulindac | 
| Package Description | 100 TABLET in 1 BOTTLE (42806-018-01) | 
| Product NDC | 42806-018 | 
| Product Type Name | HUMAN PRESCRIPTION DRUG | 
| Non Proprietary Name | Sulindac | 
| Dosage Form Name | TABLET | 
| Route Name | ORAL | 
| Start Marketing Date | 20100125 | 
| Marketing Category Name | ANDA | 
| Labeler Name | Epic Pharma, LLC | 
| Substance Name | SULINDAC | 
| Strength Number | 150 | 
| Strength Unit | mg/1 | 
| Pharmaceutical Classes | Cyclooxygenase Inhibitors [MoA],Nonsteroidal Anti-inflammatory Compounds [Chemical/Ingredient],Nonsteroidal Anti-inflammatory Drug [EPC] |